BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 22, 2004
View Archived Issues
Curis licenses Hedgehog proteins and agonists for neurological disorders to Wyeth
Read More
FTC closes review of Genzyme's acquisition of Novazyme
Read More
KV Pharmaceutical enters into agreement with Glenmark
Read More
Protein Design Labs initiates partnership for optimized antibodies
Read More
Provid Pharmaceuticals and Suntory to develop multiple sclerosis drug candidates
Read More
Natural small molecule apoptotic inducer identified
Read More
NC-381 arrests lung tumor growth
Read More
AML apoptosis induction by novel retinoid analogue
Read More
Lysosomal acid lipase reported to reduce atherosclerotic plaque formation
Read More
IM-491 and rheumatoid arthritis therapy
Read More
Two series of 5-HT6 receptor ligands newly developed at Wyeth
Read More
Italian researchers describe new camptothecin analogues and their use
Read More
New V-ATPase inhibitors and their use as apoptosis inducers in EGFR-overexpressing cells
Read More
Novel CXCR3 antagonists under study at GSK
Read More
Santen and Asahi Glass claim new prostaglandin analogues for glaucoma and other ocular disorders
Read More
New analgesic sodium channel blockers covered by Merck patent
Read More
Euroceltique researchers present new opioid analgesics
Read More
Novel antidiabetic agents discovered by Bayer researchers
Read More
D-Pharm reacquires rights to epilepsy drug DP-VPA
Read More
Xcyte Therapies and Fresenius enter HIV gene therapy collaboration
Read More
MPC-6827 causes pancreatic tumor regression in preclinical studies
Read More
FDA approval for cytarabine aNDA
Read More
Rebetol launched for pediatric use
Read More
Guilford launches marketing efforts for Aggrastat, plans PCI registration study
Read More
Orphan drug designation sought for Virucort-50
Read More
ABX-EGF enters pivotal trial for colorectal cancer
Read More
Enbrel receives E.U. approval for treatment of ankylosing spondylitis
Read More
ViroPharma restructures operations
Read More
Large Scale Biology's alpha-galactosidase A shows potential for Fabry's disease
Read More
Triapine enters NCI-sponsored clinical trials
Read More
ProAlgaZyme may decrease risk of stroke or heart attack
Read More
Abciximab and clopidogrel in elective PCI
Read More